Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald E Mager

Showing results (21-30 of 163) with videos related to

Pageof 17
Sort By:
Journal of Pharmaceutical Sciences|October 1, 2023
Contributions of William Jusko to Development of Pharmacokinetic and Pharmacodynamic Models and MethodsDonald E Mager, Robert M Straubinger
The Journal of Pharmacology and Experimental Therapeutics|December 5, 2006
Use of wavelet and fast Fourier transforms in pharmacodynamicsDonald E Mager, Darrell R Abernethy
Journal of Pharmacokinetics and Pharmacodynamics|September 16, 2015
The American Conference on Pharmacometrics 2015 (ACoP6)Jin Y Jin, Donald E Mager
Pharmaceutical Research|November 12, 2002
Receptor-mediated pharmacokinetic/pharmacodynamic model of interferon-beta 1a in humansDonald E Mager, William J Jusko
Journal of Pharmaceutical Sciences|October 16, 2002
Quantitative structure-pharmacokinetic/pharmacodynamic relationships of corticosteroids in manDonald E Mager, William J Jusko
Journal of Pharmacokinetics and Pharmacodynamics|December 17, 2009
Selection between Michaelis-Menten and target-mediated drug disposition pharmacokinetic modelsXiaoyu Yan, Donald E Mager, Wojciech Krzyzanski
Pharmaceutical Research|December 12, 2012
Interspecies modeling and prediction of human exenatide pharmacokineticsTing Chen, Donald E Mager, Leonid Kagan
Journal of Pharmaceutical Sciences|July 31, 2013
Population pharmacodynamic modeling of exenatide after 2-week treatment in STZ/NA diabetic ratsTing Chen, Leonid Kagan, Donald E Mager
Journal of Pharmaceutical Sciences|June 24, 2003
Methods of estimation of IC50 and SC50 parameters for indirect response models from single dose dataElzbieta Wyska, Donald E Mager, Wojciech Krzyzanski
CPT: Pharmacometrics & Systems Pharmacology|October 19, 2017
Cell Signaling Model Connects Vorinostat Pharmacokinetics and Tumor Growth Response in Multiple Myeloma XenograftsCharvi Nanavati, Donna Ruszaj, Donald E Mager
Pageof 17

Showing results (21-30 of 163) with videos related to

Sort By:
Pageof 17
Journal of Pharmaceutical Sciences|October 1, 2023
Contributions of William Jusko to Development of Pharmacokinetic and Pharmacodynamic Models and MethodsDonald E Mager, Robert M Straubinger
The Journal of Pharmacology and Experimental Therapeutics|December 5, 2006
Use of wavelet and fast Fourier transforms in pharmacodynamicsDonald E Mager, Darrell R Abernethy
Journal of Pharmacokinetics and Pharmacodynamics|September 16, 2015
The American Conference on Pharmacometrics 2015 (ACoP6)Jin Y Jin, Donald E Mager
Pharmaceutical Research|November 12, 2002
Receptor-mediated pharmacokinetic/pharmacodynamic model of interferon-beta 1a in humansDonald E Mager, William J Jusko
Journal of Pharmaceutical Sciences|October 16, 2002
Quantitative structure-pharmacokinetic/pharmacodynamic relationships of corticosteroids in manDonald E Mager, William J Jusko
Journal of Pharmacokinetics and Pharmacodynamics|December 17, 2009
Selection between Michaelis-Menten and target-mediated drug disposition pharmacokinetic modelsXiaoyu Yan, Donald E Mager, Wojciech Krzyzanski
Pharmaceutical Research|December 12, 2012
Interspecies modeling and prediction of human exenatide pharmacokineticsTing Chen, Donald E Mager, Leonid Kagan
Journal of Pharmaceutical Sciences|July 31, 2013
Population pharmacodynamic modeling of exenatide after 2-week treatment in STZ/NA diabetic ratsTing Chen, Leonid Kagan, Donald E Mager
Journal of Pharmaceutical Sciences|June 24, 2003
Methods of estimation of IC50 and SC50 parameters for indirect response models from single dose dataElzbieta Wyska, Donald E Mager, Wojciech Krzyzanski
CPT: Pharmacometrics & Systems Pharmacology|October 19, 2017
Cell Signaling Model Connects Vorinostat Pharmacokinetics and Tumor Growth Response in Multiple Myeloma XenograftsCharvi Nanavati, Donna Ruszaj, Donald E Mager
Pageof 17